BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19202960)

  • 1. [Cardiotoxicity of drugs used in oncology].
    Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
    Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer agents and cardiotoxicity.
    Ng R; Better N; Green MD
    Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anthracyclines and the heart].
    Mazzarello GP; Morra L
    Recenti Prog Med; 1998 Sep; 89(9):459-64. PubMed ID: 9796378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy and cardiotoxicity].
    Brestescher C; Pautier P; Farge D
    Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):443-7. PubMed ID: 8669796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of cardiotoxicity induced by anthracyclines.
    Elliott P
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity induced by tyrosine kinase inhibitors.
    Orphanos GS; Ioannidis GN; Ardavanis AG
    Acta Oncol; 2009; 48(7):964-70. PubMed ID: 19734999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic possibilities of late cardiotoxic sequelae of chemotherapy with anthracyclines].
    Elbl L; Hrstková H; Chaloupka V; Novotný J
    Vnitr Lek; 2002 Oct; 48(10):981-8. PubMed ID: 16737150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cardiac toxicity of cancer chemotherapy].
    Sequeira JF; Madruga IM; Ribeiro M; Duarte PC; Ferreira DC; Sarmento JL
    Acta Med Port; 1994 May; 7(5):311-8. PubMed ID: 8073908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxicity of antineoplastic therapy].
    Elbl L; Vásová I; Kiss I; Chaloupka V; Kubesová H; Vorlícek J
    Vnitr Lek; 2000 Mar; 46(3):178-83. PubMed ID: 11048523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular toxicity associated with cancer treatment.
    Viale PH; Yamamoto DS
    Clin J Oncol Nurs; 2008 Aug; 12(4):627-38. PubMed ID: 18676329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular toxicity of some cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].
    Saintigny P; Chouahnia K; Charniot JC; Breau JL
    Bull Cancer; 2004 Nov; 91 Suppl 3():174-84. PubMed ID: 15899625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
    Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
    Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
    Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options].
    Urbanová D; Mladosievicová B
    Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of anthracycline-induced cardiotoxicity in children: the evidence.
    van Dalen EC; Caron HN; Kremer LC
    Eur J Cancer; 2007 May; 43(7):1134-40. PubMed ID: 17383867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventing the cardiotoxic effects of anthracyclins. From basic concepts to clinical data].
    Delemasure S; Vergely C; Zeller M; Cottin Y; Rochette L
    Ann Cardiol Angeiol (Paris); 2006 Apr; 55(2):104-12. PubMed ID: 16708994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac toxicity of high-dose chemotherapy.
    Morandi P; Ruffini PA; Benvenuto GM; Raimondi R; Fosser V
    Bone Marrow Transplant; 2005 Feb; 35(4):323-34. PubMed ID: 15543194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.